Autologous transplantation of bone marrow/blood-derived cells for chronic ischemic heart disease: a systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Canadian Journal of Cardiology

• Publication date

  2014-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cjca.2014.01.013PMID 24726092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

  2014cited by this paper
• A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction.

  2013cited by this paper
• Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.

  2013cited by this paper
• Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials.

  2013cited by this paper
• Heart failure–associated hospitalizations in the United States.

  2013cited by this paper
• Adult Bone Marrow Cell Therapy Improves Survival and Induces Long-Term Improvement in Cardiac Parameters: A Systematic Review and Meta-Analysis

  2012cited by this paper
• Residual Viability Is a Predictor of the Perfusion Enhancement Obtained With the Cell Therapy of Chronic Myocardial Infarction: A Pilot Multimodal Imaging Study

  2012cited by this paper
• Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.

  2012cited by this paper
• Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

  2012cited by this paper
• Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial.

  2011cited by this paper
• Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

  2011cited by this paper
• Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction.

  2011cited by this paper
• Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina

  2011cited by this paper
• Intramyocardial Bone Marrow–Derived Mononuclear Cell Injection for Chronic Myocardial Ischemia: The Effect on Diastolic Function

  2011cited by this paper
• A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF).

  2011cited by this paper
• Bone Marrow Cell Injection for Chronic Myocardial Ischemia: The Past and the Future

  2011cited by this paper
• Effects of Stem Cell Therapy on Left Ventricular Remodeling After Acute Myocardial Infarction: A Meta‐Analysis

  2010cited by this paper
• Efficiency of Intramyocardial Injections of Autologous Bone Marrow Mononuclear Cells in Patients with Ischemic Heart Failure: A Randomized Study

  2010cited by this paper
• Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.

  2009cited by this paper
• Route of delivery and baseline left ventricular ejection fraction, key factors of bone‐marrow‐derived cell therapy for ischaemic heart disease

  2009cited by this paper
• Cardiac magnetic resonance imaging at 3 and 15 months after application of circulating progenitor cells in recanalised chronic total occlusions.

  2009cited by this paper
• Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases.

  2008cited by this paper
• Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.

  2008cited by this paper
• Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery.

  2008cited by this paper
• Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function

  2008cited by this paper
• Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone

  2008cited by this paper
• Intramyocardial Transplantation of Autologous CD34+ Stem Cells for Intractable Angina: A Phase I/IIa Double-Blind, Randomized Controlled Trial

  2007cited by this paper
• Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).

  2007cited by this paper
• Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.

  2007cited by this paper
• Differential Effect of Intracoronary Infusion of Mobilized Peripheral Blood Stem Cells by Granulocyte Colony–Stimulating Factor on Left Ventricular Function and Remodeling in Patients With Acute Myocardial Infarction Versus Old Myocardial Infarction: The MAGIC Cell-3-DES Randomized, Controlled Trial

  2006cited by this paper
• Transcoronary transplantation of progenitor cells after myocardial infarction.

  2006cited by this paper
• Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery.

  2006cited by this paper
• Recovery of Regional but Not Global Contractile Function by the Direct Intramyocardial Autologous Bone Marrow Transplantation: Results From a Randomized Controlled Clinical Trial

  2006cited by this paper
• Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis

  2006cited by this paper
• Transplantation of Blood-Derived Progenitor Cells After Recanalization of Chronic Coronary Artery Occlusion: First Randomized and Placebo-Controlled Study

  2005cited by this paper
• Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study.

  2005cited by this paper
• Cell therapy for acute myocardial infarction: where are we heading?

  2004cited by this paper
• Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

  2001cited by this paper
• Bone marrow cells regenerate infarcted myocardium

  2001cited by this paper
• Systematic reviews in health care: Assessing the quality of controlled clinical trials.

  2001cited by this paper

• Bone marrow stem cell therapy in heart failure patients with low ejection fraction: a systematic review.

  2025cites this paper
• Therapeutic use of Stem Cells, Blood and Bone Marrow Products

  2023cites this paper
• Bone marrow mesenchymal stromal cell-derived small extracellular vesicles: A novel therapeutic agent in ischemic heart diseases

  2023cites this paper
• Meta-Analysis of Percutaneous Endomyocardial Cell Therapy in Patients with Ischemic Heart Failure by Combination of Individual Patient Data (IPD) of ACCRUE and Publication-Based Aggregate Data

  2022cites this paper
• Modeling the human heart ex vivo—current possibilities and strive for future applications

  2022cites this paper
• Stem Cells in Cardiovascular Diseases: 30,000-Foot View

  2021cites this paper
• Cardiac Extracellular Matrix as a Platform for Heart Organ Bioengineering: Design and Development of Tissue-Engineered Heart.

  2021cites this paper
• Association between splenectomy and chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis

  2021cites this paper
• Stem cell-derived cell sheet transplantation for heart tissue repair in myocardial infarction

  2020cites this paper
• Cell Therapy Improves Cardiac Function in Anthracycline-Induced Cardiomyopathy Preclinical Models: A Systematic Review and Meta-Analysis

  2020cites this paper
• Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial

  2019cites this paper
• Autologous Skeletal Myoblast/Mononuclear Bone Marrow Cell Transplantation

  2019cites this paper
• Stem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies

  2018cites this paper
• [Cell therapy of chronic heart failure: State of the art].

  2018cites this paper
• Meta-Analysis of Cell Therapy Studies in Heart Failure and Acute Myocardial Infarction.

  2018cites this paper
• Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia

  2018cites this paper
• I. Aetna considers autologous skeletal myoblast transplantation experimental and investigational for members with heart failure and for all other cardiac diseases because its effectiveness has not been established. II. Aetna considers autologous intra‐coronary mononuclear bone marrow cell transplant

  2017cites this paper
• Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease

  2017cites this paper
• Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure

  2017cites this paper
• Bone marrow cells for heart repair: clinical evidence and perspectives.

  2017cites this paper
• Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies: What Can Systematic Reviews Tell Us About Cell Therapies for Ischemic Heart Disease?

  2016cites this paper
• Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies What Can Systematic Reviews Tell Us About Cell Therapies for Ischemic Heart Disease?

  2016cites this paper
• Clinical Adverse Effects of Endothelin Receptor Antagonists: Insights From the Meta‐Analysis of 4894 Patients From 24 Randomized Double‐Blind Placebo‐Controlled Clinical Trials

  2016cites this paper
• A meta-analytic review of prevalence for Brugada ECG patterns and the risk for death

  2016cites this paper
• Discrepancy between short-term and long-term effects of bone marrow-derived cell therapy in acute myocardial infarction: a systematic review and meta-analysis

  2016cites this paper
• Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia

  2016cites this paper
• Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.

  2016cites this paper
• Current evidence of the efficacy of cell-based therapies in heart failure.

  2015cites this paper
• Intramyocardial Autologous Bone Marrow-derived Stem Cells Injection for Ischemic Heart Disease Ineligible for Revascularization: A Systematic Review and Meta-analysis.

  2015cites this paper
• State of the Art on the Evidence Base in Cardiac Regenerative Therapy: Overview of 41 Systematic Reviews

  2015cites this paper
• Meta-analysis of cell therapy trials for patients with heart failure.

  2015cites this paper
• Efficacy and Safety of Bone Marrow Cell Transplantation for Chronic Ischemic Heart Disease: A Meta-Analysis

  2014cites this paper
• Systematic Review/Meta-analysis Stem Cell Therapy for the Treatment of Nonischemic Cardiomyopathy: A Systematic Review of the Literature and Meta-analysis of Randomized Controlled Trials

  2014cites this paper
• Stem cell therapy for the treatment of nonischemic cardiomyopathy: a systematic review of the literature and meta-analysis of randomized controlled trials.

  2014cites this paper
• The current state of stem cell therapeutics: Canadian approaches in the international context.

  2014cites this paper